Show Cart:
 x 
Cart empty
Free delivery to your door
 
 

 

 

 

 

 

 

Dog special offers
Cat special offers
Small special offers
Fish special offers

Have Questions?

  • Call Us: (800)557-3881
  • E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

What’s new?

49
Whisper air pumps provide reliable service at an economical cost. Efficient and...
$8.08

Are Your Hormones Making You Depressed?

Are Your Hormones Making You Depressed?

The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against the use of testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases involving the testes, pituitary and hypothalamus, it has not been approved for treating age-related decrease in testosterone levels. The U.S. National Institute on Aging is also expected to release the results of research on the security of testosterone. The study included roughly 800 elderly men with low testosterone and symptoms associated with this illness, like testosterone replacement therapy cost in india [navigate to this website] physical and sexual dysfunction. The research is expected to shed more light on the security of testosterone treatment since the men's heart health was carefully tracked.

The recent contradictory findings on testosterone treatment prompted Patel and his team to run a big systematic literature search for studies evaluating the relationship between testosterone replacement therapy and cardiovascular events among men. An estimated 13 million men in the USA suffer from low testosterone, which occurs when the body fails to make enough hormones as a result of a difficulty with the testicles or pituitary gland. This clarifies loss of energy, obvious aging and somebody's unexpected weight gain.

And many women have a knee-jerk feeling that any hormone treatment can increase their risk of breast cancer. However, clinical studies demonstrate that testosterone not only doesn't raise a woman's risk of breast cancer , it may play a vital role in warding off the disease. Glaser believes this will likely remain the status quo for some time, given the prohibitive cost of running the long term safety studies needed to win more total FDA approval.